CardioDynamics To Present At Medical Device Conference In Boston

CardioDynamicsInternational Corp., manufacturer of BioZ noninvasive digital cardiac output monitoring systems, announced that its Chief Executive Officer, Michael K. Perry, will be presenting along with seven other company executives at the Medical Device and Technologies Conference sponsored by the Wall Street Forum, on Thurs., June 10, at 1:10 p.m. in Boston.

The presentation is being conducted in front of analysts, portfolio managers and media representatives in Boston with the simultaneous attendance of institutions globally via Wall Street Forum's Web site. This Web site allows institutional investors, analysts and portfolio managers to view CardioDynamics' CEO presentation live with synchronized viewing of its corporate slide presentation.

"We are very pleased to be invited to present at this recognized institutional investor forum," stated Perry. "We have made excellent progress over the past year and believe this medium provides an unique opportunity to share our tremendous business opportunity with a broad institutional audience. We have increased our institutional ownership to approximately 25% and look forward to further increasing this percentage."

CardioDynamics, with headquarters in San Diego, is committed to fundamentally changing the way hemodynamic monitoring is performed in healthcare. The company's primary products, the BioZ System, Portable BioZ and BioZ.com utilize its proprietary Thoracic Electrical Bioimpedance (TEB) technology to noninvasively obtain data on a wide range of hemodynamic parameters. The worldwide market potential for the BioZ products is estimated to be $4 billion, together with an additional $800 million in recurring annual revenue for disposables.